Inhibition of skin graft rejection in mice by rapamycin: A novel immunosuppressive macrolide
Eng CP, Gullo-Brown J, Chang JY, et al. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide. Transplant Proc 1991; 23: 868.
Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin
Stepkowski SM, Erwin-Cohen RA, Behbod F, et al. Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin. Blood 2002; 99: 680.
Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activity
Englberger W, Hadding U, Etschenberg E, et al. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity. Int J Immunopharmacol 1988; 10: 729.
Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials
al-Sereiti MR, Abu-Am KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 1999; 37: 124.
Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner
Won J, Hur Y-G, Hur EM, et al. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur J Immunol 2003; 33: 870.